ACTRN12615000617561已完成1 期
Effect of ketamine on anxiety ratings in patients with anxiety disorders
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 25
研究概览
简要总结
ow dose ketamine has dose-related anti-anxiety effects in patients with treatment refractory GAD/SAD. These effects can be maintained during 3 months of maintenance treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •GAD patients must have a Hamilton Anxiety Scale (HAM-A) score >20
- •SP patients must have a Liebowitz Social Anxiety Scale (LSAS) self-report score >50.
排除标准
- •1.Female patients who are or intend to become pregnant, or are lactating
- •2.Participants who, in the opinion of the investigator, do not understand the information and procedures of the study, or would not be compliant with them (in particular the study restrictions and risks involved).
- •3.Any participant for whom the investigator believes, for any reason, that participation would not be an acceptable risk.
- •4.Current use of MAOIs, thyroxine or stimulants (amphetamine/methyphenidate). Use of antidepressants or other anxiolytics at stable doses > 4 weeks is acceptable.
- •5.Patients with severe acute or chronic medical illnesses.
- •6.Patients with current active suicidal ideation.
研究者
相似试验
已完成
早期 1 期
Ketamine Infusion for Social Anxiety DisorderSocial Anxiety DisorderNCT02083926Yale University18
尚未招募
3 期
Efficacy of ketamine in reducing anxiety and pain during insertion of epiduralCTRI/2022/01/039156Amrita Institute of Medical Sciences
已完成
2 期
CAP-Ketamine for Antidepressant Resistant PTSDPTSDPosttraumatic Stress DisorderNCT02655692VA Office of Research and Development163
已完成
2 期
Theanine in the Adjunctive Treatment of Generalised Anxiety Disorder: A Double-Blind Randomised Placebo-Controlled TrialGeneralized Anxiety DisorderACTRN12616000759493Dr. Jerome Sarris47
已完成
不适用
Stress Reduction and Anxiety: Effects on the Function and Structure of the BrainGeneralized Anxiety DisorderNCT01128309Massachusetts General Hospital29